Efficacy and Safety of Amantadine Hydrogen Chloride (HCl) ER Tablets in Parkinson's Disease Subjects With LID

Clinical trial NCT02153632 · TERMINATED

Trial details

NCT number: NCT02153632
Sponsor: Adamas Pharmaceuticals, Inc.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Parkinson's Disease Levodopa Induced Dyskinesia (LID)

Start date: 2014-07-30
Primary completion: 2016-05-20
Enrollment: 135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.